<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/048/SRR15719348/SRR15719348_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/047/SRR15719347/SRR15719347_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/046/SRR15719346/SRR15719346_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/044/SRR15719344/SRR15719344_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/043/SRR15719343/SRR15719343_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/048/SRR15719348/SRR15719348_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/045/SRR15719345/SRR15719345_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/045/SRR15719345/SRR15719345_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/046/SRR15719346/SRR15719346_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/044/SRR15719344/SRR15719344_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/047/SRR15719347/SRR15719347_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR157/043/SRR15719343/SRR15719343_2.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>The First Affiliated Hospital of Chongqing Medical University</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA760665</full_dataset_link><long_description>To investigate the underlying mechanism on TGR5 signaling inhibiting DCs activation.</long_description><repository>ENA</repository><description_synonyms>CORD5, type 1, retinal cone dystrophy 2, congenital stationary, ROS-GC1, CORD6, GUCY2D Leber congenital amaurosis, congenital absence of the rods and cones, RNA-seq, amaurosis congenita of Leber, CD45R., VWS1, retinal blindness, PPS1, congenital, Lca, LCA, GUCY2D cone-rod dystrophy, amaurosis congenita of Leber I, Whole Transcriptome Shotgun Sequencing, CRB, VWS, lip pit syndrome, congenital retinal blindness, GUC2D, GUC1A4, ROSGC, CD45, Rasl2-8, RETGC-1, cone-rod dystrophy caused by mutation in GUCY2D, cone-rod dystrophy type 6, Ly87, amaurosis congenita of Leber 1, LY5, retGC, CYGD, Lps, LPS, OFC6, AV026556, PPS, Ran|M1, L-CA, night blindness, Leber congenital amaurosis caused by mutation in GUCY2D, Ran/M1, lipopolysaccharides, LCA1, Leber congenital amaurosis 1, Leber congenital amaurosis type 1, GP180, cone-rod dystrophy 6, cleft lip and/or palate with mucous cysts of lower lip, B220, Leber's congenital tapetoretinal dysplasia, T200, RCD2, PIT, type 1I, Leber's congenital tapetoretinal degeneration</description_synonyms></additional><is_claimable>false</is_claimable><name></name><description>RNA-seq of LPS-primed TGR5+/+ BMDCs and TGR5-/- BMDCs treated with LCA</description><dates><last_updated>2023-05-17</last_updated><first_public>2021-09-06</first_public></dates><accession>PRJNA760665</accession><cross_references/></HashMap>